Remove 2014 Remove Healthcare Remove Healthcare Provider Remove Sales
article thumbnail

Fireside Chat with Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging

Impetus Digital

Vlado Bosanac , Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging , will join Natalie Yeadon in this upcoming episode of Healthcare Goes Digital. Impetus Digital is the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. About the webinar.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Technopreneurs Association Of Malaysia

Contrarian Sales Techniques

It brings together the ecosystems of Penang startup company by joining as a community builder in Penang in mid-2014. For example, telemedicine is a multimedia network that connects all stakeholders to provide products, services and healthcare to patients and their families, as well as healthcare providers and other stakeholders.

article thumbnail

Liron Fendell

Cadensee

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. And I was lucky enough the team at Schneider's and Clalit Healthcare , who is the owner of Schneider Hospital. We established a wholly owned subsidiary in the US and we have an office in San Diego with sales and marketing personnel.

Retail 52
article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. These actions allegedly led to the extension of Novartis’ patents.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 98